Such dangerous mutations are likely the result of exposure to, among other things, cancer-causing chemicals like benzene and certain types of weed-killing insecticides and herbicides.
Recurrent driver mutations are likely selected early during tumorigenesis49, hence their critical role in many patients and potential as compelling drug targets in different cancer types.
Neither mutation was found in any proband from 50 other families with hereditary predisposition, so the two mutations are likely family-specific rather than population-specific.
Some nucleotide substitutions change a codon for an amino acid into a signal to terminate translation, and those mutations are likely to have harmful effects.
Because the BRCA1 gene is thousands of nucleotides long, even BRCA1 genes with substantial mutations are likely to contain at least one segment of 15 nucleotides that correspond to the typical BRCA1 gene.
These mutations are likely to exist in the genome of some cancer types.
Rare post-zygotic mutations are likely to have been underestimated in the past.
This is particularly problematic as many of these mutations are likely passengers and therefore not necessarily clonal to the whole tumour.
Thus, it would appear that somatic mutations are likely an epiphenomena and/or constitute events that occur after carcinogenesis has begun [14, 15, 41, 42], as there are also cancers which are not associated with mutations [43, 44].
This second screening step is based on the assumption that functionally advantageous mutations are likely to be conserved.
Under the assumption that point mutations are likely to preserve the overall fold of the proteins, it follows the procedure for generating models.
